申请人:Kissei Pharmaceutical Co., Ltd.
公开号:US04857650A1
公开(公告)日:1989-08-15
New renin inhibitory amino acid derivatives represented by formula (I): ##STR1## wherein A represents an alkoxycarbonyl group having 2 to 7 carbon atoms, ##STR2## wherein R.sup.1 and R.sup.2 are defined as in the specification below or ##STR3## wherein X and Y are defined as in the specification herein below, n represents zero or one, Z represents --O-- or --NH--, and R represents a straight- or branched chain alkyl group having 1 to 7 carbon atoms, and pharmaceutically acceptable salts thereof, useful as a therapeutic agent are disclosed. The amino acid derivatives have a renin inhibitory effect when administered orally and are useful for treatment of hypertension, especially renin-associated hypertension.
本发明涉及一种新的肾素抑制氨基酸衍生物,其化学式为(I):##STR1## 其中A表示具有2至7个碳原子的烷氧羰基基团,##STR2## 其中R.sup.1和R.sup.2如下所述,或##STR3## 其中X和Y如下所述,n表示零或一,Z表示--O--或--NH--,R表示直链或支链烷基,其碳原子数为1至7,以及其药学上可接受的盐。这些氨基酸衍生物在口服时具有肾素抑制作用,并且可用于治疗高血压,特别是肾素相关性高血压。